Metabolic Disease News
-
Optimizing and Accelerating COVID-19 Predictive Modeling
The COVID-19 pandemic has wreaked havoc across the globe. As of July 30, 2021, nearly 197.5 million people have been infected with coronavirus, and 4.2 million people have died. The COVID-19 pandemic has resulted in significant pressure on healthcare systems around the globe. The need for effective diagnostic, prognostic and therapeutic procedures has never been as urgent as it is today. Despite ...
By JADBio
-
Ativa to validate rapid point-of-care sepsis diagnostics with Dr. James Fackler (Critical Care Medicine, Johns Hopkins
Ativa is honored to be working with Associate Professor James Fackler on developing and validating machine learning applications for critical care using digital blood samples from Ativa’s Diagnostic Workstation. Dr Fackler is a valued member of the Clinical Advisory Board and will advise Ativa on applying point of care hematology and metabolic measurement cards to provide a rapid and ...
-
Seahorse Executive Jay Teich Receives SFRBM CEO Innovator Award
Jay Teich, former Seahorse Bioscience CEO, received the first-ever CEO Innovator Award from the Society for Redox Biology and Medicine (SFRBM). This international award recognizes industry leaders who have transformed the face of scientific research in the areas of redox biology and medicine. Teich received the award in Boston on Nov. 20 during SFRBM 2015, the premier event for cutting-edge ...
-
Agilent Technologies Completes Acquisition of Seahorse Bioscience, Industry Leader in Tools for Measuring Cell Metabolism
Agilent Technologies Inc. today announced it has completed the acquisition of Seahorse Bioscience, a leader in providing instruments and assay kits for measuring cell metabolism and bioenergetics. Agilent announced its intent to acquire Seahorse on Sept. 9. Seahorse's leading technology enables researchers to better understand cell health, function and signaling, and how the cell may be impacted ...
-
Agilent Technologies to Acquire Seahorse Bioscience, Industry Leader in Tools for Measuring Cell Metabolism
Agilent Technologies Inc. (NYSE: A) and Seahorse Bioscience today announced they have signed a definitive agreement under which Agilent will acquire Seahorse Bioscience, a leader in providing instruments and assay kits for measuring cell metabolism and bioenergetics. Exploration into cell metabolism is rapidly accelerating as the links between mitochondrial function and disease are increasingly ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you